| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.03 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |